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The human gastric pathogen Helicobacter pylori is responsible for peptic ulcers and neoplasia. Both in vitro and in the
human stomach it can be found in two forms, the bacillary and coccoid forms. The molecular mechanisms of the
morphological transition between these two forms and the role of coccoids remain largely unknown. The
peptidoglycan (PG) layer is a major determinant of bacterial cell shape, and therefore we studied H. pylori PG
structure during the morphological transition. The transition correlated with an accumulation of the N-acetyl-D-
glucosaminyl-b(1,4)-N-acetylmuramyl-L-Ala–D-Glu (GM-dipeptide) motif. We investigated the molecular mechanisms
responsible for the GM-dipeptide motif accumulation, and studied the role of various putative PG hydrolases in this
process. Interestingly, a mutant strain with a mutation in the amiA gene, encoding a putative PG hydrolase, was
impaired in accumulating the GM-dipeptide motif and transforming into coccoids. We investigated the role of the
morphological transition and the PG modification in the biology of H. pylori. PG modification and transformation of H.
pylori was accompanied by an escape from detection by human Nod1 and the absence of NF-jB activation in epithelial
cells. Accordingly, coccoids were unable to induce IL-8 secretion by AGS gastric epithelial cells. amiA is, to our
knowledge, the first genetic determinant discovered to be required for this morphological transition into the coccoid
forms, and therefore contributes to modulation of the host response and participates in the chronicity of H. pylori
infection.
Citation: Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, et al. (2006) Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS
Pathog 2(9): e97. DOI: 10.1371/journal.ppat.0020097
Introduction
Helicobacter pylori is a human pathogen with an unique
niche: the stomach. The presence of this bacterium is always
associated with chronic gastritis, and less often with severe
duodenal ulcers, gastric adenocarcinoma, or mucosa-associ-
ated lymphoid tissue lymphoma. H. pylori has the interesting
ability to convert from bacillary to coccoid forms. The
coccoid forms appear in stationary phase and can also be
induced under stress conditions, for example, following
modiﬁcation of pH, O2 tension, or temperature [1,2], or
exposure to antibiotics such as amoxicillin [3,4]. However,
there is still controversy regarding the biological role of this
form. Both forms are commonly observed in the human
stomach [5,6]. Coccoids are viable but noncultivable, and this
has led to the suggestion that the coccoid form is the
persisting form, allowing H. pylori to spread between human
hosts. Coccoid forms contain a reasonable quantity of ATP [7]
and an active respiratory chain [8–10]; it is also viable as
assessed by viability staining [11–14]. Various proteins
(including VacA and CagA) and activities (for example,
urease activity) are detectable, but it is not clear whether
there is any de novo protein synthesis [15]. Attempts to revert
coccoid bacteria to spiral under laboratory conditions have
failed so far. In contrast, several groups have reported
colonization of mice with coccoid bacteria and have
subsequently isolated spiral bacteria from their stomachs,
indicating that under certain conditions coccoids may revert
back to spiral bacteria [16–19].
Despite interest in this subject, little is known about the
process of morphological transition into coccoid forms.
Proteome and transcriptome analyses have failed to identify
proteins involved in the transition [7,20–23]. The cdrA gene
has been implicated in coccoid formation [24], but these
results are controversial because the cdrA gene is inactivated
in several strains, including the two sequenced strains 26695
and J99. Hence, CdrA is unlikely to have a major role, if any,
in coccoid formation. It is known, however, that the lipid
composition of H. pylori changes substantially during the
transition into coccoid forms [25].
One of the main determinants of bacterial shape is the
peptidoglycan (PG) layer (for a recent review see [26]). Costa
et al. [27] implicated a modiﬁcation of the muropeptide
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bacillary to the coccoid form: the N-acetyl-D-glucosaminyl-
b(1,4)-N-acetylmuramyl-L-Ala–D-Glu (GM-dipeptide) motif
accumulated in the sacculus after 2 d of liquid culture. This
motif lacks the diamino acid, meso-diaminopimelic acid
(mesoDAP), required for PG transpeptidation. Possibly, a
change to a looser PG macromolecule could explain the
shape transition of H. pylori from spiral to coccoid.
Here, we studied the genetic determinants involved in the
accumulation of the GM-dipeptide motif. Several alternative
mechanisms could explain this phenomenon (see Protocol S1
and Figure S2), and PG hydrolases could be involved. We
describe the construction of a mutant strain with a mutation
of the amiA gene—encoding a putative PG hydrolase—that is
impaired in the accumulation of the GM-dipeptide motif; it is
also defective in the transition from spiral bacteria into
coccoid forms. We show that the phenotype of morphological
transition and PG modiﬁcation is associated with impaired
sensing by the Nod1 pathway, impaired activation of NF-jB,
and impaired cytokine production by AGS gastric epithelial
cells. We thus identiﬁed a new mechanism for bacterial
escape from the innate immune system.
Results
Accumulation of the GM-Dipeptide Motif in the PG of
Various Strains of H. pylori
We puriﬁed and analyzed the PG from the sequenced strain
26695 and from the strain NCTC11637 used as a control. No
major difference between chromatograms of the two strains
was observed (Figures 1 and S1). Muropeptide composition
analysis of H. pylori PG showed an accumulation of the GM-
dipeptide motif in strain 26695 during the stationary phase,
as previously observed in strain NCTC11637 (Figures 1 and
S1; [27]). Interestingly, the accumulation of the GM-dipeptide
(peak 4 in Figures 1 and S1) coincided with a decrease of N-
acetyl-D-glucosaminyl-b(1,4)-N-acetylmuramyl-L-Ala–c-D-
Glu-mesoDAP (GM-tripeptide) (peak 1).
We used a targeted approach to investigate the molecular
mechanisms responsible for the accumulation of the GM-
dipeptide motif (see Protocol S1 and Figure S2). We
constructed mutants of hp0087 (encoding a putative pepti-
dase), hp1118 (encoding a gamma-glutamyltranspeptidase),
hp0645 (encoding the lytic transglycosylase Slt), hp1572
(encoding the lytic transglycosylase MltD), and hp0772
(encoding the putative N-acetylmuramoyl-L-alanine amidase
AmiA). Detailed information for each gene and protein is
available on the PyloriGene database (http://genolist.pasteur.
fr/PyloriGene/genome.cgi). Only in the amiA mutant was the
accumulation of GM-dipeptide impaired (peak 4 in Figures 1
and S3). The PG of this mutant contained less of this motif at
8 h, 24 h, and 48 h (about 1.9-, 2.3-, and 2.9-fold less,
respectively) than the parental strain (Figure 1). The amount
of GM-tripeptide (peak 1) remained stable between expo-
nential and stationary phase. The residual amount of GM-
dipeptide present in the PG of the amiA mutant is probably
due to the decrease of MurE activity in stationary phase
(Figure S4).
Morphology of the amiA Mutant
We studied the morphology of the amiA mutant during the
different growth stages using scanning electron microscopy
(SEM) and after ruthenium red staining using transmission
electron microscopy (TEM) to visualize PG in the periplasmic
space) (Figure 2). The amiA mutant was observed as very long
bacterial chains of up to 30 bacteria per chain after 4 h of
culture (Figure 2D and 2E), while the parental strain 26695
showed normal individual rod-shaped bacteria (Figure 2A).
Sections stained with ruthenium red revealed completely
formed septa in the amiA mutant (Figure 2G and 2H),
indicating daughter cell separation was defective. The
parental strain, 26695, showed rod, U, donut, and coccoid
forms after 2 d, 1 wk, and 1 mo of culture (Figure 2B and 2C;
unpublished data), while the amiA mutant remained in long
chains of rod-shaped bacteria (Figure 2F). Far fewer amiA
mutant cells were in coccoid forms after similar times of
growth (Table 1). Therefore, the amiA mutant seems to be
blocked both for cell separation and for the transition into
coccoid forms.
Complementation of the amiA Mutant
Next, we tried to complement the phenotype by introduc-
ing a wild-type amiA gene at a different locus, that of the rdxA
gene (Figure S5). Disruption of the rdxA gene confers
metronidazole (mtz) resistance to H. pylori [28]. However,
the insertion of a copy of the amiA gene into the rdxA gene in
the same orientation was lethal for H. pylori. When the amiA
gene was inserted into the rdxA gene in the opposite
orientation, transformants were obtained. PCR analysis
showed two populations of transformants: (1) bacteria with
amiA in rdxA and the wild-type amiA gene inactivated by the
kanamycin (km) cassette (mtz
Rkm
R mutants), and (2) mutants
with amiA in rdxA and with the wild-type amiA gene restored
(mtz
Rkm
S mutants). Only the second type of mutants
(mtz
Rkm
S) complemented the ﬁlamentation phenotype and
restored the transition into coccoid forms. Hence, the
observed phenotype could not be due to a secondary
mutation. To eliminate the possibility of polar effects of the
amiA mutant on the downstream gene, we also constructed a
mutant of the downstream gene, hp0771. The hp0771 mutant
showed a normal bacillary form during the ﬁrst day of
culture, and the capacity to adopt the coccoid form. We
quantiﬁed the proportions of bacillary and coccoid forms
(Table 1): the amiA mutant was the only strain impaired in the
transition into coccoid forms.
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Synopsis
Helicobacter pylori is a human pathogen responsible for gastric
diseases such as ulcers and gastric cancers. Despite the host’s
vigorous immune response, H. pylori is capable of persisting for
decades in its human host. H. pylori is found in biopsies in two
distinct forms, a spiral rod form and a coccoid form. Chaput et al.
investigated the molecular mechanisms leading to the transition of
H. pylori from a spiral rod–shaped organism to a coccoid organism.
The morphological transition is accompanied by modifications of
the bacterial cell wall peptidoglycan. The authors have identified the
AmiA protein as essential for this morphological transition and
modification of the cell wall peptidoglycan. Additionally, the authors
show that the cell wall modifications and morphological transition
allow these coccoid forms to escape detection by the immune
system and therefore could participate in the persistence of H. pylori
infection during the lifetime of its human host.Amoxicillin Effects
Some stress signals, including amoxicillin treatment, can
induce the morphological transition into coccoid forms [4].
We investigated the response of the amiA mutant to
amoxicillin. First, we determined the minimum inhibitory
concentration (MIC) of amoxicillin: it was identical for the
amiA mutant and the parental strain 26695 (0.06 lg/ml). After
overnight culture, 10 lg/ml amoxicillin was added to the
medium, and after 3 h of antibiotic treatment, bacteria were
observed using SEM. The amiA mutant formed chains of
spherical bacteria (Figure 3), rod-shaped bacteria, and, most
frequently, both rod-shaped and spherical bacteria. Thus, the
impaired morphological transition is not an artifact and does
not result from steric hindrance of bacterial chain formation
(see Table 1 for quantiﬁcation). Therefore, AmiA is required
both for PG modiﬁcations and for the morphological
transition.
Epithelial Cell Response to H. pylori PG and Coccoid Forms
Having demonstrated that the transition into coccoid
forms is a process controlled by AmiA, we investigated the
biological role of the coccoid forms. The accumulation of the
GM-dipeptide motif (Figure 1, peak 4) correlated with the
almost disappearance of the GM-tripeptide motif (Figure 1,
peak 1). These two muropeptides are the agonists of the
human Nod2 (hNod2) and human Nod1 (hNod1) proteins,
respectively [29]. Sensing of H. pylori PG by Nod1 is essential
for the inﬂammatory response by gastric epithelial cells [30].
Therefore, the switch from being a hNod1 agonist to being a
hNod2 agonist during coccoid formation could affect the
ability of gastric epithelial cells to detect H. pylori and to
develop an inﬂammatory response.
NF-jB activation in HEK293T cells via stimulation by
hNod1 and hNod2 was tested with digested PG extracted
from the amiA mutant and the parental strain after 8 h and 48
h of growth (Figure 4A). Nod1 responses showed highest NF-
jB activation with PG extracted after 8 h of growth and less
activation with PG extracted at 48 h of growth, for both wild-
type strains (26695 and NCTC11637). Thus, the activation
decreased with decreasing abundance of the GM-tripeptide
in H. pylori PG. For the amiA mutant, hNod1 responses were
the same when cells were stimulated with PG extracted after 8
h or 48 h of growth, consistent with the unchanging GM-
tripeptide content of the PG. Conversely, hNod2 responses
revealed a higher NF-jB activation with PG extracted after 48
h of growth than with PG extracted after 8 h (Figure 4B).
These results suggest that spiral bacteria preferentially
induce NF-jB via hNod1 and coccoid bacteria via hNod2.
However, hNod2 (as hNod1) senses muropeptides and not
polymeric PG; we therefore tested whether naturally occur-
ring PG turnover products can stimulate hNod2. These
products are mainly anhydromuropeptides generated by
endogenous PG hydrolases called lytic transglycosylases. We
compared the hNod2-dependent activation of NF-jBb yH.
pylori PG digested by a muramidase (M1) and a lytic
transglycosylase (Slt70 from Escherichia coli). Figure S6 shows
the chromatogram of the Slt70-digested PG of H. pylori and
the structural assignment of each anhydromuropeptide. As
Figure 1. Muropeptide Profile of H. pylori PG
PG from parental strain 26695 (A) and its amiA isogenic mutant (B) were purified and digested with the muramidase M1 (mutanolysin). The generated
muropeptides were separated by HPLC. The HPLC profiles show muropeptide composition after 8 h, 24 h, and 48 h of bacterial growth. Each peak
structure was assigned by MALDI-TOF mass spectrometry and corresponds to a different muropeptide: (1) GM-tripeptide, (2) GM-tetrapeptide, (3) GM-
tetrapeptide-glycine, (4) GM-dipeptide, and (5) GM-pentapeptide. Dimers were then eluted: (6) GM-tetrapeptide-tripeptide-MG, (7) GM-tetrapeptide-
tetrapeptide-glycine-MG, (8) GM-tetrapeptide-tetrapeptide-MG, and (9) GM-tetrapeptide-pentapeptide-MG. Finally, anhydromuropeptides were eluted:
(10) G(anh)M-pentapeptide, (11) and (12) G(anh)M-tetrapeptide-tripeptide-MG, (13) and (14) G(anh)M-tetrapeptide-tetrapeptide-MG, and (15) G(anh)M-
tetrapeptide-pentapeptide-MG.
DOI: 10.1371/journal.ppat.0020097.g001
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Morphological Transition of H. pyloriexpected from our previous results [31], anhydromuropep-
tides were able to induce NF-jB in a Nod1-dependent
manner (Figure 4C). Surprisingly, anhydromuropeptides were
unable to induce NF-jB in a Nod2-dependent manner. To
further investigate the structural basis of hNod2 sensing, we
compared the Nod2-dependent activation of NF-jB by the
GM-dipeptide and its anhydro derivative, G(anh)M-dipeptide
([anh]M indicates N-acetyl-anhydromuramic acid). The GM-
dipeptide motif produced by H. pylori was detected via hNod2
in a dose-dependent manner. However, Nod2 did not sense
the GanhM-dipeptide motif (Figure 4D). We conclude that PG
turnover products are agonists of the Nod1 pathway [31], but
are unable to induce the Nod2 pathway. Accordingly, rod-
shaped H. pylori induced NF-jB in HEK293T cells and IL-8
production by gastric epithelial cells, but coccoid bacteria
had no NF-jB or IL-8 stimulatory activities (Figure 4E and
4F). As epithelial cells do not respond to coccoid forms or to
PG turnover products from coccoid forms, our study suggests
that coccoid forms provide a route for immune escape for H.
pylori.
Discussion
Since the ﬁrst observation of microbes, bacterial shape has
been considered to be largely invariant and a characteristic
feature of each species. It has therefore been used as a major
taxonomic determinant. Nevertheless, several bacteria are
known to change morphology during genetic developmental
programs such as sporulation or asymmetric cell division. H.
pylori undergoes morphological transition from spiral to
coccoid. Previous attempts to identify speciﬁc markers or a
dedicated genetic program involved in this morphological
transition have been inconclusive [7,20–23]. Nevertheless, in
1999, Costa and colleagues correlated the morphological
transition with a modiﬁcation of H. pylori PG muropeptide
composition [27], that is, the accumulation of the GM-
dipeptide motif.
The PG layer is a major determinant of bacterial cell shape,
so we felt that identifying the genetic determinants involved
in the observed PG modiﬁcation could help elucidate the
morphological transition. There are several possible explan-
ations for the accumulation of the GM-dipeptide motif (see
Figure 2. Morphologies of H. pylori
(A–F) SEM of H. pylori during exponential-phase growth (4 h of culture (A, D, and E) and after 1 wk of culture (B, C, and F) of the parental strain 26695 (A–
C) and the amiA mutant (D–F).
(G and H) TEM sections of the amiA mutant after ruthenium staining. The amiA mutant is able to form a complete septum without final daughter cell
separation. Chains of the amiA mutant contained up to 30–40 bacteria.
DOI: 10.1371/journal.ppat.0020097.g002
Table 1. Quantification of the Number of Coccoid Forms
Strain Days of Growth Percent Coccoids
a Number of Counted Bacteria
26695 1 wk 55.79% 699
26695 amiA
  1 wk 6.26% 405
26695 771::Tn3-km 1 wk 57.24% 449
26695 þ amoxicillin 3–4 h
b 56.64% 685
26695 amiA
  þ amoxicillin 3–4 h
b 32.60% 1,003
aIncludes U and donut forms. For the amiA mutant, counts of bacteria correspond to individual bacteria that composed each chain.
bTime of exposure to amoxicillin after 18 h of growth without antibiotic.
DOI: 10.1371/journal.ppat.0020097.t001
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Morphological Transition of H. pyloriProtocol S1 and Figure S2). It could result from a defect in
precursor synthesis in the cytoplasm due to (1) a decrease of
MurE activity blocking PG precursor synthesis at the step
where mesoDAP is added to the uracyl diphosphate-M-
dipeptide, (2) insufﬁcient mesoDAP to allow synthesis of
precursors, or (3) the presence of a carboxy/endopeptidase,
cleaving between the second and the third amino acid
residue. This carboxy/endopeptidase activity could be in
either the cytoplasm (cleaving PG precursors with more than
two amino acid residues in the stem peptide) or the periplasm
(directly cleaving macromolecular PG). We also considered
the potential roles of the annotated PG hydrolases Slt, MltD,
and AmiA in this process [31]. Protocol S1 summarizes the
various hypotheses and the data supporting or inconsistent
with each of them. We identiﬁed the amiA gene as necessary
for the PG modiﬁcation. The amiA mutant was impaired in
the transition to coccoid forms. This is, to our knowledge, the
ﬁrst identiﬁcation of a genetic determinant required for the
morphological transition of H. pylori, and also directly
implicates PG modiﬁcation in determining bacterial mor-
phology. To our knowledge, this is the ﬁrst description of a
putative PG hydrolase directly involved in maintenance of
bacterial cell shape. N-acetylmuramoyl-L-alanine amidases
contribute to the separation of daughter cells in E. coli [32],
but three genes encoding amidases had to be deleted from E.
coli to observe a changed phenotype, whereas in H. pylori
inactivation of a single gene was sufﬁcient to produce a
comparable ﬁlamentation phenotype.
Interestingly, the accumulation of GM-dipeptide motif
(Figure 1, peak 4) coincided with a proportional decrease of
the GM-tripeptide motif (Figure 1, peak 1). In the amiA
mutant, the proportion of GM-tripeptide remained stable
and the amounts of the GM-dipeptide were very low. No
signiﬁcant changes were observed for the other monomeric
muropeptides. This is consistent with the activity of a
periplasmic carboxy/endopeptidase that recognizes the c-D-
glutamyl-meso-diaminopimelic acid bond.
The AmiA protein is structured as a bimodular protein: a
signal peptide followed by an N-terminal domain without
homology to any sequences in the NCBI non-redundant
database (amino acids 1–177), a linker peptide of variable
length composed of KKEIP repeats (amino acids 178–190),
and an C-terminal domain (amino acids 191–440) homolo-
gous to CwlU and CwlV, which are predicted to have an N-
acetylmuramoyl-L-alanine amidase activity [33]. PG amidases
cleave the PG in the periplasm between the N-acetylmuramic
acid residue and the ﬁrst amino acid residue of the peptide
moiety, L-alanine. However, the amidase activity of AmiA and
its closest homologs has never been conﬁrmed, so it is
plausible that AmiA has a carboxy/endopeptidase activity.
Alternatively, AmiA might be bifunctional, with an N-
terminal carboxy/endopeptidase activity and a C-terminal
amidase activity. It is also possible that AmiA has an amidase
activity that is unable to cleave stem peptides with less than
three amino acid residues such as the human serum amidase
or peptidoglycan recognition protein L [34]. This would lead
to the elimination of stem peptides with three to ﬁve amino
acid residues, and consequently the accumulation of GM-
dipeptides. We are currently studying the biochemistry of the
AmiA protein to resolve this issue.
We have shown that the morphological transition is
regulated by AmiA. In its absence, the transition can be
Figure 3. Effect of Amoxicillin on H. pylori Morphology
SEM of H. pylori strain 26695 (A and B) and its isogenic amiA mutant (C and D) grown without amoxicillin (A and C) and after 3–4 h exposure to 10 lg/ml
amoxicillin (B and D). Amoxicillin treatment of the amiA mutant bypasses the requirement of amiA for the morphological transition, indicating that
absence of coccoid forms was not due to sterical hindrance of the bacterial chains.
DOI: 10.1371/journal.ppat.0020097.g003
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Morphological Transition of H. pyloriinduced by treatment with amoxicillin, a b-lactam antibiotic.
Exposure to amoxicillin bypasses the requirement for the
AmiA protein, suggesting that one of the other determinants
might be a penicillin-binding protein. Amoxicillin preferen-
tially targets H. pylori PBP2 [4], a homolog of E. coli PBP2. A
PBP2 conditional mutant of E. coli becomes spherical at
nonpermissive temperature, [35] and, consequently, PBP2 is
believed to drive lateral PG synthesis.
The role of PG metabolism in the transition into coccoid
forms suggests this might be a regulated process rather than a
random degeneration of H. pylori cells. Therefore, coccoid
forms might be important in H. pylori physiology. Consistent
with this, Segal and colleagues showed that coccoid forms are
able to translocate CagA—one of the major virulence factors
and the only known effector protein of the H. pylori type IV
secretion system—and induce cellular changes [36]. Coccoid
forms express other virulence factors, including the func-
tional CagA. We showed that coccoid forms modulate NF-jB
activation. The morphological transition of H. pylori is
accompanied by a decrease in the abundance of the GM-
tripeptide motif, the hNod1 agonist, and this decrease
minimizes the activation of NF-jB (via hNod1) in HEK293T
cells and abolishes IL-8 induction in gastric epithelial cells.
Thus, the coccoid forms might allow the bacteria to escape or
modulate the host response and thereby to persist in the
human stomach. To our knowledge, this would be a
previously undescribed mechanism for pathogens to respond
to a chronic inﬂammatory response.
Nevertheless, coccoid forms may potentially stimulate
epithelial cells via hNod2, in particular in an inﬂamed
mucosa. Indeed, the hNod2 pathway can be induced by
TNF-a and INF-c in an NF-jB-dependent manner [37,38].
During a chronic infection of the gastric mucosa, coccoid
forms of H. pylori would preferentially stimulate NF-jB via
Figure 4. hNod1- and hNod2-Dependent Activation of NF-jBb yH. pylori PG
(A and B) PG samples from strain NCT11637, strain 26695, and the isogenic amiA mutant prepared after 8 h and 48 h of growth, were digested with M1
(mutanolysin) to generate muropeptides and used to stimulate hNod1 (A) and hNod2 (B).
(C and D) PG samples were also digested with recombinant Slt70 from E. coli to generate anhydromuropeptides, used to stimulate hNod1 and hNod2,
and compared to M1-generated muropeptides (C). hNod1 and hNod2 agonists were used at 10 nM and PGs at 0.3 lg/ml. Finally, purified GM-dipeptide
and its anhydrous derivative G(anh)M-dipeptide were also tested for their ability to stimulate hNod2 (D).
(E) H. pylori at different growth stages (spiral versus coccoid) and different multiplicity of infection (MOI) were used to stimulate the HEK293T cells, and
NF-jB activation was determined.
(F) The same experiment as in (E) was performed with the AGS gastric epithelial cell line, and IL-8 secretion was determined. TNF-a (20 ng/ml) was used
as a positive control.
MDP, muramyldipeptide; NS, nonstimulated; TriDAP, L-alanyl-D-glutamyl-mesoDAP.
DOI: 10.1371/journal.ppat.0020097.g004
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Morphological Transition of H. pylorihNod2. However, hNod2 (as hNod1) senses muropeptides
instead of polymeric PG. Muropeptides can be generated
either by host lysozyme or by H. pylori endogeneous lytic
transglycosylases such as Slt. While lysozyme is abundant in
paneth cells, it is almost absent from the mucus layer [39],
where H. pylori preferentially resides [40]. Furthermore, like
Gram-negative bacteria in general, H. pylori is insensitive to
lysozyme’s activity. Muropeptides generated by the endoge-
nous lytic transglycosylases such as G(anh)M-dipeptide
(Figure 4D) are not sensed by the hNod2 pathway. Hence,
coccoid forms are unlikely to be seen by the host, suggesting
these could function as a mechanism of escape from and
modulation of the host’s innate immune system. Campylobacter
jejuni also undergoes morphological transition into coccoid
forms. C. jejuni usually causes acute gastroenteritis, but a
recent study has associated long-term intestinal colonization
of patients by C. jejuni with the onset of intestinal mucosa-
associated lymphoid tissue lymphoma [41]. Possibly, coccoid
forms of C. jejuni are similarly involved in establishing chronic
infection.
In conclusion, we report the amiA gene as the ﬁrst genetic
determinant to our knowledge discovered that is involved in
the transition of spiral bacteria into coccoid forms. Further
characterization of AmiA should be of interest in determin-
ing how H. pylori regulates the transition from bacillary into
coccoid forms and for investigations of the physiological
importance, in vitro and in vivo, of this particular bacterial
form.
Materials and Methods
Bacteria, cells, and growth conditions. E. coli MC1061 [42] and
DH5a were used as hosts for the construction and preparation of
plasmids. They were cultivated in Luria Bertani solid or liquid
medium supplemented as appropriate with spectinomycin (100 lg/
ml) or kanamycin (40 lg/ml) or both. H. pylori strain 26695 [43] was
used to construct mutants. PG was extracted from strains 26695 and
NCTC11637. H. pylori was grown microaerobically at 37 8C on blood
agar plates or in liquid medium consisting of brain–heart infusion
(Oxoid, http://www.oxoid.com) with 0.2% b-cyclodextrin (Sigma-
Aldrich, http://www.sigmaaldrich.com) supplemented with antibiot-
ic–antifungic mix [44]. H. pylori mutants were selected on 20 lg/ml
kanamycin. HEK293T cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium containing 10% fetal calf serum. Prior to trans-
fection, HEK293T cells were seeded into 24-well plates at a density of
10
5 cells/ml as described previously [45].
Construction of mutants and complementation. Genes were
disrupted as described previously [46]. H. pylori mutants were
constructed by allelic exchange after transformation with suicide
plasmids or PCR products carrying the gene of interest interrupted
by a nonpolar cassette aphA-3 [46] or miniTn3-km transposon and
selected on kanamycin. PCRs were used to conﬁrm that correct allelic
exchange occurred. Gene constructions were sequenced to ensure
sequence ﬁdelity. All reagents, enzymes, and kits were used according
to manufacturers’ recommendations. Midiprep (HiSpeed Plasmid
Midi Kit) and DNA extraction kits (QIAamp DNA extraction kit) were
purchased from Qiagen (http://www.qiagen.com).
The plasmid pILL2000 was used to construct the amiA mutant.
pILL570 carrying ORF hp0772 (amiA gene) was used as the template
for an Expand High Fidelity PCR (Amersham, http://www.
amershambiosciences.com) with oligonucleotides 772–1 (59-gaugau-
gauggtaccaaggattttaacttcataagtc-39, in which the underlined sequence
corresponds to a KpnI site) and 772–2 (59-aucaucaucggatccaacacg-
cagcgattgatcgtctctaac-39, in which the underlined sequence corre-
sponds to a BamHI site). PCR products were digested with BamHI
(Amersham) and KpnI (Amersham) and ligated (T4 DNA ligase,
Amersham) with the aphA-3 nonpolar cassette digested with the same
endonucleases.
Complementation experiments were done by insertion of the amiA
gene in the rdxA locus, either in the same orientation or in the reverse
orientation. The amiA mutant was used as a recipient for the suicide
plasmid or PCR products for complementation. Constructs were
made as follows. For the same orientation, the construct was made by
three-time PCR [47]. Each of three fragments and the ﬁnal fragment
used for transformation were obtained by Expand High Fidelity PCR.
First, three fragments were obtained: (i) a 300-bp fragment
corresponding to the 59-end of rdxA obtained with oligonucleotides
954F (59-atgaaatttttggatcaagaaaaaag-39) and CC772in954–1 (59-CA-
CAAGCACtacaaattaacctccattgaaatagatgtgcgctgc-39, with the capital
letters corresponding to the sequence hybridizing with the 59-end of
the amiA gene); (ii) a 1,320-bp fragment corresponding to the amiA
gene obtained with oligonucleotides CCrbs772 (59-gagggttaatttg-
tagtgcttgtg-39) and CC772stop (59-ctaatcattcttgctgaagaaac-39); and
(iii) a 300-bp fragment corresponding to the 39-end of rdxA obtained
with oligonucleotides 954Rev (59-tcacaaccaagtaatcgcatcaac-39) and
CC772in954–2 (59-GTTTCTTCAGCAAGAATGATTAGtacctggagg-
gaataatgcaatgctatatcgctgtgggg-39, with the capital letters correspond-
ing to the sequence hybridizing with the 39-end of the amiA gene). The
ﬁnal PCR product was obtained by using a mixture of these three
fragments as a template and oligonucleotides 954F and 954Rev.
For the reverse orientation, the pILL570-rdxA plasmid was used as
the template for an Expand High Fidelity PCR (Amersham) with
oligonucleotides 954–2KpnI (59-cggggtacctacatgcaaaatctctatccg-39,i n
which the underlined sequence corresponds to a KpnI site) and 954–
1BamHI (59-cgcggatccgtgtggtaacaactcgctggg-39, in which the under-
lined sequence corresponds to a BamHI site). The amiA gene was
ampliﬁed using the following primers: 772-compl-1Bis (59-cggggatcc-
gagggttaatttgtagtgcttgtgaggttagggg-39, in which the underlined se-
quence corresponds to a BamHI site) and 772-compl-2Bis (59-
cgggtaccctaatcattcttgctgaaaaactatcaatgcc-39, in which the underlined
sequence corresponds to a KpnI site). PCR products were digested
with BamHI (Amersham) and KpnI (Amersham) and ligated (T4 DNA
ligase, Amersham).
The hp0087 mutant was obtained following natural transformation
of H. pylori with a construct made of three PCR products [47]. Each of
three fragments and a ﬁnal fragment used for transformation were
obtained by Expand High Fidelity PCR. First, three fragments were
obtained: (i) a 300-bp fragment corresponding to the 59-end of
HP0087 obtained with oligonucleotides 87-NotI (59-ataagaatgcggccg-
cATGcgttattttcttgtagttttc-39) and 87-in1 (59-GTTAGTCACCCGGG-
TACtgactttcatatctagccatgggg-39, with the capital letters
corresponding to the sequence hybridizing with the 59-end of the
aphA-3 gene); (ii) a 850-bp fragment corresponding to the aphA-3
cassette; and (iii) a 300-bp fragment corresponding to the 39-end of
HP0087 obtained with oligonucleotides 87-EcoRI (59-ggaatTCAattcg-
catttaaagggcttg-39, with the capital letters corresponding to the stop
codon of HP0087) and 87-in2 (59-TACCTGGAGGGAATAATGgacta-
catccttaaaaacgcc-39, with the capital letters corresponding to the
sequence hybridizing with the 39-end of the aphA-3 gene). The ﬁnal
PCR product was obtained by using a mixture of these three
fragments as a template and oligonucleotides 87-NotI and 87-EcoRI.
Gamma-glutamyltranspeptidase (hp1118) and hp0771 mutants were
obtained by gene interruption with miniTn3; there are no genes
downstream from hp0771 and hp1118 with the same direction of
transcription. The interruption was generated in E. coli DH5a by
insertion of miniTn3 into plasmids carrying either hp0771 or hp1118
(C. Ecobichon, C. Chevalier, and A. Labigne, unpublished data).
Plasmids carrying the insertions were checked by PCR and used to
transform H. pylori 26695. Mutants were validated by PCR analysis.
The hp1118 mutant was also tested for the absence of gamma-
glutamyltranspeptidase activity as previously described [48].
Peptidoglycan extraction and analysis. Liquid cultures of H. pylori
parental strain and isogenic mutant strains were stopped after
various times of growth and chilled in an ice-ethanol bath. The crude
murein sacculus was immediately extracted in boiling sodium dodecyl
sulphate (4% ﬁnal concentration). Puriﬁcation steps and high-
pressure liquid chromatography (HPLC) analyses were as described
previously [49]. Recombinant lytic transglycosylase Slt70 was puriﬁed
as previously described [50]. Mutanolysin (M1)– or Slt70-digested
samples (M1 from Sigma-Aldrich) were analyzed by HPLC on a
Hypersil ODS18 reverse-phase column (250 3 4.6 mm, 3-lm particle
size) with a methanol (HPLC grade, Fisher Scientiﬁc, http://www.
ﬁsherscientiﬁc.com) gradient from 0% to 15% in sodium phosphate
buffer (pH 4.3 to 5.0). Chromatograms were obtained by monitoring
at 206 nm. Each peak was collected, desalted, and identiﬁed by
MALDI-MS as described previously [51].
Quantiﬁcation of MurE activity. Bacteria were collected by
centrifugation (3,000 g, 20 min, 4 8C) from 400 ml of culture after 8
h, 24 h, and 48 h of H. pylori growth. The bacterial pellets were washed
with potassium phosphate buffer (20 mM, 0.5 mM magnesium
dichloride and 2-mercaptoethanol [pH 7.4]), and resuspended in
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(http://www.soniﬁer.com) at 20W per minute until the lysate was clear.
The samples were dialysed twice against the same buffer. MurE
activity in these crude extracts was determined as described
previously [52].
Electron microscopy. Bacteria were washed with PBS (pH 7.4) and
stained with ruthenium red or used directly for SEM. For ruthenium
red staining, bacteria were preﬁxed with 2.5% glutaraldehyde, in
0.075% ruthenium red, and 0.1 M cacodylate buffer for 1 h. Samples
were rinsed with 0.1 M cacodylate buffer and post-ﬁxed in 1%
osmium tetraoxide in 0.1 M cacodylate buffer for 2 h. They were
washed in water three times and then dehydrated in a series of
ethanol concentrations. Finally, the samples were embedded in Spurr,
and ultrathin sections were made. Grids were viewed by TEM with a
JEOL Jem 1010 microscope (http://www.jeol.com).
For SEM, samples were washed in PBS, preﬁxed in 2.5%
glutaraldehyde in 0.1 M cacodylate buffer for 30 min, and then
rinsed in 0.2 M cacodylate buffer. After post-ﬁxation in 1% osmium
tetraoxide (in 0.2 M cacodylate buffer), bacteria were dehydrated in a
series of ethanol concentrations. Specimens were critical-point dried
using carbon dioxide, then coated with gold and examined with a
JEOL JSM-6700F SEM.
MIC. To determine the MIC for amoxicillin, suspensions of H.
pylori estimated to contain 10
8 bacteria/ml (OD600nm of 0.1) were
serially diluted and grown on plates containing various concen-
trations of amoxicillin. The MIC was deﬁned as the amoxicillin
concentration leading to a decrease of three log of colony-forming
units per milliliter as compared to growth without amoxicillin.
Expression plasmids, transient transfections, and NF-jB activation
assays. The expression plasmid for FLAG-tagged hNod1 was from
Gabriel Nun ˜ez (University of Michigan Medical School, Ann Arbor,
Michigan, United States) and has been described previously [53]. The
expression plasmid for hNod2 was from Gilles Thomas (Fondation
Jean Dausset/CEPH, Paris, France). HEK293T cells were used for
transfections as described previously [45]. Synergistic activation of
NF-jB by PGs, muramyl peptides, and related compounds in cells
overexpressing Nod1 or Nod2 was studied as described by Inohara et
al. [54]. Brieﬂy, HEK293T cells were transfected overnight with 1 ng
of hNod1 or 1 ng of hNod2 plus 75 ng of Ig luciferase reporter
plasmid. PG samples (0.1 lg/ml) were digested with 0.25 lg/ll
mutanolysin. At the same time, 0.3 lg of PG preparations or 10
pmol of muramyl peptides were added to the cell culture medium,
and synergistic NF-jB-dependent luciferase activation was measured
after 24 h of co-incubation. NF-jB-dependent luciferase assays were
performed in duplicate, and data reported represent at least three
independent experiments. Data were standardized with positive
controls: N-acetylmuramic acid-dipeptide for hNod2 and N-acetyl-
muramic acid-tripeptide for hNod1. hNod1 and hNod2 were
activated with H. pylori PG (0.3 lg/ml) digested with M1 or Slt70 as
previously described [29].
Supporting Information
Figure S1. Chromatograms of H. pylori 26695 and NCTC11637 Strains
after Two Different Times of Culture (8 h and 48 h)
These results are consistent with previous observations [27] and with
the results obtained with strain 26695 (Figure 1).
Found at DOI: 10.1371/journal.ppat.0020097.sg001 (305 KB PPT).
Figure S2. Schematic Representation of Hypotheses Concerning the
Accumulation of GM-Dipeptide in the PG of H. pylori during the
Transition from Spiral into Coccoid Forms
This accumulation might be generated by the increase in the
cytoplasm of PG precursors carrying a dipeptide (then incorporated
into periplasmic PG) or by carboxy/endopeptidase activity present in
the periplasm (represented by red scissors). The modiﬁcation of the
PG precursor pool in cytoplasm might be due to (i) insufﬁcient
mesoDAP preventing normal biosynthesis or (ii) a decrease of MurE
activity, which is then the limiting step in the biosynthesis of
precursors and leads to an increase of dipeptide precursor.
Found at DOI: 10.1371/journal.ppat.0020097.sg002 (174 KB PPT).
Figure S3. Chromatograms of H. pylori 26695 Isogenic Mutants for slt,
mltD, hp0087, and hp1118 after 48 h of Culture
The four mutants accumulate the GM-dipeptide at 48 h of growth to
the same extent as the parental strain 26695 (see Figure 1).
Found at DOI: 10.1371/journal.ppat.0020097.sg003 (273 KB PPT).
Figure S4. MurE Activity in H. pylori Strain 26695 and amiA Mutant
after 8 h, 24 h, and 48 h of Growth
For each time point, the speciﬁc MurE activity was measured in crude
protein extracts. The speciﬁc activity is expressed in nanomoles per
minute per milligram.
Found at DOI: 10.1371/journal.ppat.0020097.sg004 (40 KB PPT).
Figure S5. Schematic Representation of the amiA Locus and rdxA
Gene
The amiA gene was inactivated with a nonpolar kanamycin cassette.
Complementation studies involved inserting the amiA gene into the
rdxA locus. Note that amiA was introduced without a promoter, and,
therefore, expression of the amiA gene is driven by the rdxA locus
endogenous promoters. HP0771 was inactivated by a miniTn3-km
transposon, since the downstream gene is oriented in the opposite
direction.
Found at DOI: 10.1371/journal.ppat.0020097.sg005 (44 KB PPT).
Figure S6. H. pylori PG Was Digested with Recombinant Slt70 from E.
coli and Analyzed by HPLC
Each peak was collected and the structure was determined by MALDI-
TOF mass spectrometry. Peaks 1 to 9 correspond to the following
anhydromuropeptides: (1) G(anh)M-tripeptide, (2) G(anh)M-tetrapep-
tide, (3) G(anh)M-tetraglycine-peptide, (4) G(anh)M-dipeptide, (5)
G(anh)M-pentapeptide, (6) G(anh)M-tri-tetra-(anh)MG, (7) G(anh)M-
tetra-tetraglycine-(anh)MG, (8) G(anh)M-tetra-tetra-(anh)MG, and (9)
G(anh)M-penta-tetra-(anh)MG.
Found at DOI: 10.1371/journal.ppat.0020097.sg006 (66 KB PPT).
Protocol S1. Supplementary Data
Found at DOI: 10.1371/journal.ppat.0020097.sd001 (79 KB DOC).
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